V

Vanderbilt University Medical Center | Vanderbilt - Ingram Cancer Center

Research site
(Unclaimed)
Location
3322 West End Avenue Suite 1000, Nashville, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Luspatercept
ASTX727
Domvanalimab

Parent organization

This site is a part of Vanderbilt University Medical Center

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body (STAR-221)

This randomized Phase 3 open-label study will compare the efficacy of the T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (I...

Enrolling
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Capecitabine
Drug: Fluorouracil

Extension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Astex-...

Invitation-only
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Drug: ASTX727

A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants:Participants recei...

Enrolling
Beta-thalassemia
Myelodysplastic Syndromes (MDS)
Drug: Luspatercept

Trial sponsors

Arcus Biosciences logo
Astex Pharmaceuticals logo
Celgene logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems